Fibrinolytic cross-talk: a new mechanism for plasmin formation

Autor: Romaric Lacroix, Tiphaine Dejouvencel, Laurent Plawinski, H. Roger Lijnen, Loïc Doeuvre, Eduardo Anglés-Cano, Françoise Dignat-George
Přispěvatelé: Hémostase, bio-ingénierie et remodelage cardiovasculaires (LBPC), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut Galilée-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Sérine protéases et physiopathologie de l'unité neurovasculaire, Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Physiopathologie de l'Endothelium, Vascular research center of Marseille (VRCM), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre-Imagerie, Neurosciences, et Application aux Pathologies (CI-NAPS - UMR 6232), Normandie Université (NU)-Normandie Université (NU)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Center for Molecular and Vascular Biology, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Inserm European Community's Seventh Framework Programme (FP7/2007-2013) Excellentie financiering, KU Leuven Lower-Normandy Regional Council, European Project: 201024,EC:FP7:HEALTH,FP7-HEALTH-2007-A,ARISE(2008), Université Paris Diderot - Paris 7 (UPD7)-Université Paris 13 (UP13)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Galilée, Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)
Rok vydání: 2010
Předmět:
MESH: Signal Transduction
Plasmin
medicine.medical_treatment
MESH: Antifibrinolytic Agents
urokinase
Cell Communication
MESH: Fibrinolysin
030204 cardiovascular system & hematology
Biochemistry
MESH: Fibrinolysis
Mice
0302 clinical medicine
Antifibrinolytic agent
MESH: Plasminogen
MESH: Animals
Fibrinolysin
Cells
Cultured

0303 health sciences
biology
medicine.diagnostic_test
Chemistry
Fibrinolysis
MESH: Plasminogen Activators
lysine-binding site
Hematology
Antifibrinolytic Agents
Extracellular Matrix
Cell biology
Aminocaproic Acid
platelets
plasminogen
monocytes
Signal Transduction
MESH: Cells
Cultured

medicine.drug
Proteolysis
MESH: Receptor Cross-Talk
Immunology
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
MESH: Extracellular Matrix
endothelial microparticles
Article
MESH: Urokinase-Type Plasminogen Activator
Plasminogen Activators
03 medical and health sciences
MESH: 6-Aminocaproic Acid
MESH: Cell Communication
medicine
Animals
Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

MESH: Mice
030304 developmental biology
Urokinase
MESH: Humans
Activator (genetics)
Receptor Cross-Talk
Cell Biology
Urokinase-Type Plasminogen Activator
Fibronectin
MESH: Protein Processing
Post-Translational

biology.protein
Protein Processing
Post-Translational

Plasminogen activator
Zdroj: Blood
Blood, 2010, 115 (10), pp.2048-56. ⟨10.1182/blood-2009-06-228817⟩
Blood; Vol 115
Blood, American Society of Hematology, 2010, 115 (10), pp.2048-56. ⟨10.1182/blood-2009-06-228817⟩
ISSN: 1528-0020
0006-4971
Popis: Fibrinolysis and pericellular proteolysis depend on molecular coassembly of plasminogen and its activator on cell, fibrin, or matrix surfaces. We report here the existence of a fibrinolytic cross-talk mechanism bypassing the requirement for their molecular coassembly on the same surface. First, we demonstrate that, despite impaired binding of Glu-plasminogen to the cell membrane by ϵ-aminocaproic acid (ϵ-ACA) or by a lysine-binding site–specific mAb, plasmin is unexpectedly formed by cell-associated urokinase (uPA). Second, we show that Glu-plasminogen bound to carboxy-terminal lysine residues in platelets, fibrin, or extracellular matrix components (fibronectin, laminin) is transformed into plasmin by uPA expressed on monocytes or endothelial cell–derived microparticles but not by tissue-type plasminogen activator (tPA) expressed on neurons. A 2-fold increase in plasmin formation was observed over activation on the same surface. Altogether, these data indicate that cellular uPA but not tPA expressed by distinct cells is specifically involved in the recognition of conformational changes and activation of Glu-plasminogen bound to other biologic surfaces via a lysine-dependent mechanism. This uPA-driven cross-talk mechanism generates plasmin in situ with a high efficiency, thus highlighting its potential physiologic relevance in fibrinolysis and matrix proteolysis induced by inflammatory cells or cell-derived microparticles.
Databáze: OpenAIRE